Quanome Technologies, Inc. (QNME)
NASDAQ: QNME · Real-Time Price · USD
0.6894
+0.3754 (119.55%)
Aug 4, 2026, 1:42 PM EDT - Market open
Quanome Technologies Revenue
Quanome Technologies had revenue of $1.33M in the quarter ending March 31, 2026, with 167.00% growth. This brings the company's revenue in the last twelve months to $22.18M, up 302.96% year-over-year. In the fiscal year ending June 30, 2025, Quanome Technologies had annual revenue of $17.79M, down -2.87%.
Revenue (ttm)
$22.18M
Revenue Growth
+302.96%
P/S Ratio
1.20
Revenue / Employee
$235,994
Employees
94
Market Cap
23.73M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 17.79M | -524.73K | -2.87% |
| Jun 30, 2024 | 18.32M | 5.44M | 42.28% |
| Jun 30, 2023 | 12.87M | 3.27M | 34.02% |
| Jun 30, 2022 | 9.61M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
QNME News
- 1 year ago - Lakeside Announces Fiscal 2025 Third Quarter and Nine-Month Results - GlobeNewsWire
- 1 year ago - LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION - PRNewsWire
- 1 year ago - Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results - PRNewsWire
- 1 year ago - Lakeside Secures New Distribution Agreements with Kelun Pharmaceutical - PRNewsWire
- 1 year ago - Lakeside Partners with Huiyu Pharmaceutical to Revolutionize Oncology Drug Distribution - PRNewsWire
- 1 year ago - Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary - PRNewsWire
- 1 year ago - Lakeside Holding to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference - PRNewsWire
- 1 year ago - Lakeside Strengthens Market Position in China's Pharmaceutical Logistics with Key Sinopharm(Hubei) Contracts - PRNewsWire